Endoscopic sleeve gastroplasty

From WikiMD's WELLNESSPEDIA

Endoscopic Sleeve Gastroplasty (ESG) is a medical procedure used to treat obesity. It is a less invasive alternative to other bariatric surgeries, such as gastric bypass surgery and gastric sleeve surgery.

Procedure[edit]

The procedure involves the use of an endoscope, a flexible tube with a camera and light at the end, which is inserted through the patient's mouth and into the stomach. The surgeon then uses a device attached to the endoscope to suture the stomach, reducing its size by approximately 70%. This limits the amount of food the stomach can hold, leading to weight loss.

Candidates[edit]

Candidates for ESG are typically individuals who have a BMI of 30 or higher, and who have not been able to lose weight through traditional methods such as diet and exercise. However, as with all medical procedures, the suitability of ESG is determined on a case-by-case basis, taking into account the patient's overall health and medical history.

Risks and Complications[edit]

While ESG is less invasive than other bariatric surgeries, it still carries potential risks and complications. These may include nausea, vomiting, abdominal pain, and in rare cases, leakage from the sutures.

Effectiveness[edit]

Studies have shown that ESG can lead to significant weight loss. One study found that patients lost an average of 15% of their total body weight one year after the procedure. However, as with all weight loss procedures, the long-term success of ESG depends on the patient's commitment to a healthy lifestyle.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.